Unassociated Document

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VZDFIp53vr6YoCIVrFOiZZ4zdYXBFH9XX6WBmDPjiKcmnB3rxalX+PsUf7Rz9lAD iED2UQo4jNIoqgSMf02Ztw== 0001140361-09-021821.txt : 20090928 0001140361-09-021821.hdr.sgml : 20090928 20090928132242 ACCESSION NUMBER: 0001140361-09-021821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090924 FILED AS OF DATE: 20090928 DATE AS OF CHANGE: 20090928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA TAU FINANZIARIA SPA CENTRAL INDEX KEY: 0001092601 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 091089723 MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 STREET 2: 00144 CITY: ROME ITALY FORMER NAME: FORMER CONFORMED NAME: SIGMA TAU FINANZIARIA DATE OF NAME CHANGE: 19990805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIGMA TAU INTERNATIONAL SA CENTRAL INDEX KEY: 0001170881 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 091089722 BUSINESS ADDRESS: STREET 1: 18 AVENUE DE LA PORTE NEUVE CITY: LUXEMBOURG STATE: N4 ZIP: L-2227 MAIL ADDRESS: STREET 1: 18 AVENUE DE LA PORTE NEUVE CITY: LUXEMBOURG STATE: N4 ZIP: L-2227 FORMER NAME: FORMER CONFORMED NAME: SIGMA TAU FINANCE INTERNATIONAL SA DATE OF NAME CHANGE: 20020409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-452-0001 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigma-Tau Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001385625 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 091089720 BUSINESS ADDRESS: STREET 1: 800 SOUTH FREDERICK AVENUE STREET 2: SUITE 300 CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 1-800-447-0169 MAIL ADDRESS: STREET 1: 800 SOUTH FREDERICK AVENUE STREET 2: SUITE 300 CITY: GAITHERSBURG STATE: MD ZIP: 20877 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sigma-Tau America S.A. CENTRAL INDEX KEY: 0001385930 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 091089721 BUSINESS ADDRESS: STREET 1: 19-21, BOULEVARD DU PRINCE HENRI CITY: L-1724 LUXEMBOURG STATE: N4 ZIP: 00000 BUSINESS PHONE: 1-800-447-0169 MAIL ADDRESS: STREET 1: 19-21, BOULEVARD DU PRINCE HENRI CITY: L-1724 LUXEMBOURG STATE: N4 ZIP: 00000 4 1 doc1.xml FORM 4 X0303 4 2009-09-24 0 0000812796 DOR BIOPHARMA INC DORB 0001092601 SIGMA TAU FINANZIARIA SPA VIA SUDAFRICA, 20 ROME L6 00144 ITALY 0 0 1 0 0001170881 SIGMA TAU INTERNATIONAL SA 19-21 BLVD. DU PRINCE HENRI L-1724 LUXEMBOURG N4 LUXEMBOURG 0 0 1 0 0001385930 Sigma-Tau America S.A. 19-21 BLVD. DU PRINCE HENRI L-1724 LUXEMBOURG N4 LUXEMBOURG 0 0 1 0 0001385625 Sigma-Tau Pharmaceuticals, Inc. 9841 WASHINGTONIAN BLVD SUITE 500 GAITHERSBURG MD 20878 0 0 1 0 Common Stock 2009-09-24 4 P 0 3952569 0.253 A 45619236 I Indirect Common Stock Warrant (right to buy) 0.278 2009-09-24 4 J 0 1 0 A 2009-09-27 2014-09-27 Common Stock 1976284 1 I Indirect Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. (?Pharmaceuticals?). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. (?America?). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. (?International?). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A. This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals? purchase of 3,952,569 shares of common stock on September 24, 2009. The expiration date of the warrant may be accelerated at the Issuer?s option if the Issuers?s common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended. Exhibit List Exhibit 99 - Joint Filer Information /s/ Maurizio Terenzi, Proxy-holder authorized 2009-09-28 EX-99.1 2 misc1.htm MISCELLANEOUS EXHIBITS Unassociated Document

Exhibit 99

Joint Filer Information

Name:	Sigma-Tau International S.A.

Address:
	19-21 Boulevard du Prince Henri
	L-1724 Luxembourg

Designated Filer:	Sigma-Tau Finanziaria S.p.A.

Issuer & Ticker Symbol:	DOR BioPharma, Inc. (DORB)

Date of Earliest
Transaction Required
to be Reported:	9/24/09

Signature:	/s/ Gregg Lapointe
	Name: Gregg Lapointe
	Title: Attorney-in-fact
	SIGMA-TAU INTERNATIONAL S.A.

Name:	Sigma-Tau America S.A.

Address:	19-21 Boulevard du Prince Henri
	L-1724 Luxembourg

Designated Filer:	Sigma-Tau Finanziaria S.p.A.

Issuer & Ticker Symbol:	DOR BioPharma, Inc. (DORB)

Date of Earliest
Transaction Required
to be Reported:	9/24/09

Signature:	/s/ Gregg Lapointe
	Name: Gregg Lapointe
	Title: Attorney-in-fact
	SIGMA-TAU AMERICA S.A.

Name:	Sigma-Tau Pharmaceuticals, Inc.

Address:	9841 Washingtonian Blvd, Suite 500
	Gaithersburg, Maryland 20878
	USA

Designated Filer:	Sigma-Tau Finanziaria S.p.A.

Issuer & Ticker Symbol:	DOR BioPharma, Inc. (DORB)

Date of Earliest
Transaction Required
to be Reported:	9/24/09

Signature:	/s/ Gregg Lapointe
	Name: Gregg Lapointe
	Title: Chief Executive Officer
	SIGMA-TAU PHARMACEUTICALS, INC.

-----END PRIVACY-ENHANCED MESSAGE-----